Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/537Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Suri, Anil | - |
| dc.date.accessioned | 2015-05-27T10:31:49Z | - |
| dc.date.available | 2015-05-27T10:31:49Z | - |
| dc.date.issued | 2012-10 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/537 | - |
| dc.description.abstract | Cancer immunotherapy is a promising field with limited success, also due to lack of tumor-specific targets. In our attempt of exploring novel biomarkers and immunotherapeutic targets against cancer, we have discovered a novel cancer testis antigen, SPAG9, in cancers of different histological origin and demonstrated its potential role in oncogenesis. | en_US |
| dc.publisher | Landes Bioscience | en_US |
| dc.title | Cancer testis antigens: A new paradigm for cancer therapy | en_US |
| dc.contributor.coauthor | Saini, Shikha | - |
| dc.contributor.coauthor | Sinha, Abhilasha | - |
| dc.contributor.coauthor | Agarwal, Sumit | - |
| dc.contributor.coauthor | Verma, Archana | - |
| dc.contributor.coauthor | Parashar, Deepak | - |
| dc.contributor.coauthor | Singh, Swarnendra | - |
| dc.contributor.coauthor | Gupta, Namita | - |
| dc.contributor.coauthor | Jagadish, Nirmala | - |
| dc.keyword | Cancer testis antigens, SPAG9, biomarkers, Immunotherapy, Cancer vaccines | en_US |
| dc.journal | Oncoimmunology | en_US |
| dc.volumeno | 1 | en_US |
| dc.issueno | 7 | en_US |
| dc.pages | 1194-1196 | en_US |
| Appears in Collections: | Genes and Proteins, Publications | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2012 ONCOIMUNNOLOGY REVIEW.pdf | 281.42 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.